LAVA Therapeutics N.V. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing – amended

Third party tender offer – amended

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Oliger Christy J.

Wadlinger Mary E.

Backstrom Jay T.

News Filter

Completion of Acquisition or Disposition of Assets, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Material Modification to Rights of Security Holders, Change in Directors, Officers or Compensation

Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist From Nasdaq

Shareholder Vote Results

XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement

XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Proxy related to merger

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness